Two Sigma Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-185,058
Closed -$690K 2594
2024
Q3
$690K Sell
185,058
-39,759
-18% -$148K ﹤0.01% 1572
2024
Q2
$1.26M Sell
224,817
-11,500
-5% -$64.4K ﹤0.01% 1431
2024
Q1
$1.24M Buy
236,317
+14,300
+6% +$74.9K ﹤0.01% 1464
2023
Q4
$1.16M Buy
222,017
+199,500
+886% +$1.04M ﹤0.01% 1568
2023
Q3
$355K Buy
+22,517
New +$355K ﹤0.01% 1922
2021
Q4
Sell
-4,300
Closed -$240K 2842
2021
Q3
$240K Sell
4,300
-22,800
-84% -$1.27M ﹤0.01% 2189
2021
Q2
$1.16M Sell
27,100
-84,600
-76% -$3.62M ﹤0.01% 1568
2021
Q1
$4.66M Buy
111,700
+29,700
+36% +$1.24M 0.01% 878
2020
Q4
$3.82M Buy
82,000
+66,900
+443% +$3.12M 0.01% 932
2020
Q3
$641K Buy
15,100
+3,500
+30% +$149K ﹤0.01% 1710
2020
Q2
$557K Buy
+11,600
New +$557K ﹤0.01% 1848
2019
Q3
Sell
-10,600
Closed -$590K 2429
2019
Q2
$590K Buy
10,600
+4,200
+66% +$234K ﹤0.01% 1743
2019
Q1
$323K Buy
+6,400
New +$323K ﹤0.01% 1963
2018
Q3
Sell
-6,000
Closed -$454K 2439
2018
Q2
$454K Buy
+6,000
New +$454K ﹤0.01% 1956
2017
Q4
Sell
-4,800
Closed -$286K 2407
2017
Q3
$286K Buy
4,800
+1,500
+45% +$89.4K ﹤0.01% 1942
2017
Q2
$260K Buy
+3,300
New +$260K ﹤0.01% 2040
2016
Q1
Sell
-36,491
Closed -$3.24M 2158
2015
Q4
$3.24M Sell
36,491
-23,709
-39% -$2.1M 0.02% 580
2015
Q3
$4.47M Buy
60,200
+49,300
+452% +$3.66M 0.03% 500
2015
Q2
$881K Buy
+10,900
New +$881K 0.01% 1178